Used as a key intermediate in the synthesis of pharmaceuticals, particularly in the development of central nervous system (CNS) active agents. Its structure supports the creation of compounds with antidepressant, anxiolytic, or stimulant properties. Commonly employed in research settings for designing novel psychoactive substances and studying structure-activity relationships in amine-based drugs. Also utilized in the preparation of selective serotonin or dopamine reuptake inhibitors due to the electron-withdrawing effect of the trifluoromethoxy group, which enhances metabolic stability and blood-brain barrier penetration.